Eczema drug shows promise in breast cancer trial
Disease control
Recruiting now
This early-phase trial is testing whether adding dupilumab (an eczema and asthma drug) to standard immunotherapy and chemotherapy can safely improve outcomes for people with locally advanced triple-negative breast cancer. About 15 participants will receive the combination before …
Phase: EARLY_PHASE1 • Sponsor: Rima Patel • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC